Home » Stocks » WAT

Waters Corporation (WAT)

Stock Price: $268.33 USD 5.43 (2.07%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 16.65B
Revenue (ttm) 2.30B
Net Income (ttm) 503.93M
Shares Out 62.06M
EPS (ttm) 8.03
PE Ratio 33.43
Forward PE 27.70
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $268.33
Previous Close $262.90
Change ($) 5.43
Change (%) 2.07%
Day's Open 262.38
Day's Range 261.18 - 269.20
Day's Volume 378,757
52-Week Range 162.36 - 269.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 2 weeks ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Con...

Business Wire - 1 month ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today announced that Dr. Pearl S. Huang, President and CEO of Cygnal Therapeutics and venture partner at Flagship Pioneering, has...

Business Wire - 1 month ago

DAEGU, South Korea--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) has formally expanded its long-standing, collaborative relationship with Dr. Sunghwan Kim of Kyungpook National University to...

Business Wire - 1 month ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today announced that Sherry Buck will step down as Chief Financial Officer, effective December 31, 2020, in order to pursue anoth...

Seeking Alpha - 1 month ago

Waters Corporation occupies a leading position in attractive markets. Historically, the company has outperformed the S&P 500 by a wide margin.

24/7 Wall Street - 2 months ago

It is almost hard to believe, in what has been one of the most unbelievable years in recent history, that Halloween is this weekend and Thanksgiving is right around the corner.

Other stocks mentioned: EXR, FCX, GOOGL, JAZZ, LLY, MDT, PH, RCL, WMT
Seeking Alpha - 2 months ago

Waters Corporation (WAT) CEO Udit Batra on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Waters (WAT) delivered earnings and revenue surprises of 13.09% and 8.52%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 2 months ago

Waters' (WAT) third-quarter 2020 results reflect benefits from strong momentum across the Americas and Europe, and improved performance in the pharmaceutical and industrial market.

Benzinga - 2 months ago

Shares of Waters (NYSE:WAT) moved higher by 0.1% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 1.41% year over year to $2.16, which ...

Business Wire - 2 months ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced third quarter 2020 sales of $594 million, a 3% increase as reported, compared to sales of $577 million for the t...

Zacks Investment Research - 2 months ago

Waters' (WAT) third-quarter results are likely to reflect strength across new product cycle and the liquid chromatography space. However, coronavirus headwinds might have been concerns.

Zacks Investment Research - 2 months ago

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 3 months ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will webcast its Q3 2020 financial results conference call live on Tuesday, October 27th at 8:00 a.m. eastern time. To listen to ...

Business Wire - 3 months ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) announced this week at Biotech Week Boston the establishment of Immerse™ Cambridge, a new Waters' research laboratory in the he...

Business Wire - 4 months ago

BOSTON--(BUSINESS WIRE)-- #DSP--LabMinds, Inc., a pioneer in automation for solution preparation in life sciences, today announced that Waters Corporation (NYSE: WAT), a global leader in speci...

Zacks Investment Research - 4 months ago

4 Stocks to Watch on Rising Demand for Scientific Instruments

Other stocks mentioned: BRKR, MTD, PKI
Zacks Investment Research - 4 months ago

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Seeking Alpha - 5 months ago

Waters Corporation (WAT) CEO Chris O'Connell on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Waters' (WAT) second-quarter results benefit from cost-cutting strategies. However, coronavirus-led disruptions remained headwinds.

Zacks Investment Research - 5 months ago

Waters (WAT) delivered earnings and revenue surprises of 37.25% and 0.11%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 5 months ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced second quarter 2020 sales of $520 million, a 13% decrease as reported, compared to sales of $599 million for the...

Zacks Investment Research - 5 months ago

Waters (WAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 5 months ago

Waters' (WAT) second-quarter 2020 results are likely to reflect new product introductions and large molecule strength.

The Motley Fool - 6 months ago

The healthcare company's second-quarter results appear better than expected.

Business Wire - 6 months ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will webcast its Q2 2020 financial results conference call live on Tuesday, July 28th at 8:00 a.m. eastern time. To listen to the...

Business Wire - 6 months ago

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) (“Waters” or the “Company”) today announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Off...

Seeking Alpha - 6 months ago

7 Picks For June 2020: 3 Of Them Are Severely Undervalued

Other stocks mentioned: CVS, FUPBY, MCK, MMM
Kiplinger - 7 months ago

The stock market has been remarkably resilient this year amid the pandemic and recession.

Other stocks mentioned: AAL, OXY, VNO, WU
Seeking Alpha - 7 months ago

Hidden Stock Market Gems: Waters Corporation

Zacks Investment Research - 7 months ago

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 8 months ago

Drab Near-Term Prospects for Scientific Instruments Industry

Other stocks mentioned: HBIO, MTD, PKI
Seeking Alpha - 8 months ago

Waters Corporation's (WAT) CEO Christopher O'Connell on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Waters' (WAT) first-quarter 2020 results hurt by negative impact of the coronavirus pandemic.

Zacks Investment Research - 8 months ago

Waters (WAT) delivered earnings and revenue surprises of -19.01% and -6.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

Waters' (WAT) first-quarter 2020 results are likely to reflect new product introductions and large molecule strength. However, uncertainties in China and coronavirus woes are concerns.

Zacks Investment Research - 10 months ago

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 11 months ago

Waters' (WAT) fourth-quarter 2019 results benefit from solid momentum in governmental & academic market. However, softness in pharmaceutical and industrial markets remains a concern.

Seeking Alpha - 11 months ago

Waters Corporation's (WAT) CEO Christopher O'Connell on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 11 months ago

Waters (WAT) delivered earnings and revenue surprises of 5.96% and 0.33%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 11 months ago

Although, expectations for fourth-quarter 2019 earnings are negative at present, results so far are far better than initially anticipated.

Other stocks mentioned: NBIX, NS, RMR, SAVE
Zacks Investment Research - 11 months ago

Waters' (WAT) fourth-quarter 2019 results are likely to have benefited from new product introductions. However, uncertainties in China and Europe remained concerns.

Zacks Investment Research - 11 months ago

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 11 months ago

Here we pick four S&P 500 technology stocks that are well poised to provide solid returns in 2020.

Other stocks mentioned: AAPL, MCHP, MSCI
Zacks Investment Research - 1 year ago

Waters (WAT) agrees to acquire Andrew Alliance in a bid to expand technology portfolio.

Zacks Investment Research - 1 year ago

Waters (WAT) agrees to acquire Andrew Alliance in a bid to expand the technology portfolio.

Zacks Investment Research - 1 year ago

Here we pick six technology stocks that are likely to post positive earnings surprises this season.

Other stocks mentioned: AAPL, MKSI, PERI, SIMO, SYNA
Zacks Investment Research - 1 year ago

Scientific Instruments Industry Outlook: Prospects Look Good

Other stocks mentioned: HBIO, MTD, PKI
Zacks Investment Research - 1 year ago

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Seeking Alpha - 1 year ago

Waters Corporation (WAT) CEO Chris O'Connell on Q3 2019 Results - Earnings Call Transcript

About WAT

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry inst... [Read more...]

Industry
Diagnostics & Research
IPO Date
Nov 16, 1995
CEO
Christopher O'Connell
Employees
7,000
Stock Exchange
NYSE
Ticker Symbol
WAT
Full Company Profile

Financial Performance

In 2019, WAT's revenue was $2.41 billion, a decrease of -0.55% compared to the previous year's $2.42 billion. Earnings were $592.20 million, a decrease of -0.27%.

Financial Statements

Analyst Forecasts

According to 18 analysts, the average rating for WAT stock is "Hold." The 12-month stock price forecast is 227.93, which is a decrease of -15.06% from the latest price.

Price Target
$227.93
(-15.06% downside)
Analyst Consensus: Hold